DREAM Study to Evaluate Omega-3 Fatty Acids in Treatment of Dry Eye
May 6, 2014
On April 28, 2014, details were submitted to clinicaltrials.gov of the DREAM study (Dry Eye Assessment and Management Study).
There is a hypothesis that omega-3 supplementation is an effective treatment for Dry Eye Disease (DED). The objective of the DREAM study is to evaluate that hypothesis by testing the effectiveness and safety of omega-3 fatty acid supplementation in relieving symptoms of moderate to severe dry eye disease in a randomized, double blind clinical trial.
The primary outcome measure of the trial will be the mean of change from baseline in OSDI score at 6 and 12 months (note: for lay readers, OSDI stands for Ocular Surface Disease Index and is a method of using various symptoms to determine the extent of dry eye disease).
Recruitment is expected to begin in June 2014 at sites throughout the country.
Click here for further details about the trial, including criteria for participation.
Jump down to form below to submit your own comments